Literature DB >> 33218296

Using Clinical Trial Data to Estimate the Costs of Behavioral Interventions for Potential Adopters: A Guide for Trialists.

Louise B Russell1,2, Laurie A Norton1, David Pagnotti1, Christianne Sevinc3, Sophia Anderson1, Darra Finnerty Bigelow1, Lauren G Iannotte1, Michael Josephs1, Ryan McGilloway1, Iwan Barankay4, Mary E Putt5, Peter P Reese2,5,6, David A Asch1,2,7,8, Lee R Goldberg1,7, Shivan J Mehta1,2,3,7, Monique S Tanna7, Andrea B Troxel9, Kevin G Volpp1,2,3,7,8.   

Abstract

Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff to encourage healthy behaviors are becoming increasingly prevalent and important in health innovation and improvement efforts. Although considerations of cost are key to their wider adoption, cost information is lacking because the resources required cannot be costed using standard administrative billing data. Pragmatic clinical trials that test behavioral interventions are potentially the best and often only source of cost information but rarely incorporate costing studies. This article provides a guide for researchers to help them collect and analyze, during the trial and with little additional effort, the information needed to inform potential adopters of the costs of adopting a behavioral intervention. A key challenge in using trial data is the separation of implementation costs, the costs an adopter would incur, from research costs. Based on experience with 3 randomized clinical trials of behavioral interventions, this article explains how to frame the costing problem, including how to think about costs associated with the control group, and describes methods for collecting data on individual costs: specifications for costing a technology platform that supports the specialized functions required, how to set up a time log to collect data on the time staff spend on implementation, and issues in getting data on device, overhead, and financial incentive costs.

Entities:  

Keywords:  behavioral intervention; clinical trial; costing; medication adherence; outcomes research; pragmatic trial; preventive services; translating research into practice

Year:  2020        PMID: 33218296      PMCID: PMC7772275          DOI: 10.1177/0272989X20973160

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  3 in total

1.  Cost-Effectiveness of Four Financial Incentive Programs for Smoking Cessation.

Authors:  Louise B Russell; Kevin G Volpp; Pui L Kwong; Benjamin S Cosgriff; Michael O Harhay; Jingsan Zhu; Scott D Halpern
Journal:  Ann Am Thorac Soc       Date:  2021-12

2.  Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.

Authors:  Ravi B Parikh; William Ferrell; Jonathan Wakim; Joelle Williamson; Neda Khan; Michael Kopinsky; Mohan Balachandran; Peter E Gabriel; Yichen Zhang; Lynn M Schuchter; Lawrence N Shulman; Jinbo Chen; Mitesh S Patel; Christopher R Manz
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

3.  Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial.

Authors:  Peter P Reese; Iwan Barankay; Mary Putt; Louise B Russell; Jiali Yan; Jingsan Zhu; Qian Huang; George Loewenstein; Rolf Andersen; Heidi Testa; Adam S Mussell; David Pagnotti; Lisa E Wesby; Karen Hoffer; Kevin G Volpp
Journal:  JAMA Netw Open       Date:  2021-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.